F11R and cancer: The extracellular localization of the JAM-A cis-dimerization site makes it a readily targetable structure, and its spatial separation from the trans-dimerization site (which functions in physiological adhesion processes) offers assurance of the potential to selectively interrupt JAM-A function in cancer without impacting the important physiological functions of JAM-A.